Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery
ClinicalTrials.gov study NCT06530719. IPD Sharing: NO. Countries: 0. Publications: 0.
Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation
ClinicalTrials.gov study NCT03153358. IPD Sharing: NO. Countries: 0. Publications: 0.
Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong
ClinicalTrials.gov study NCT03519958. IPD Sharing: Not stated. Countries: 0. Publications: 0.
EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism
ClinicalTrials.gov study NCT02859077. IPD Sharing: YES. Countries: 0. Publications: 0.
Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC
ClinicalTrials.gov study NCT01215474. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy
ClinicalTrials.gov study NCT02788058. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation
ClinicalTrials.gov study NCT02795884. IPD Sharing: NO. Countries: 0. Publications: 0.
Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
ClinicalTrials.gov study NCT04870190. IPD Sharing: NO. Countries: 0. Publications: 0.
Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation
ClinicalTrials.gov study NCT05962021. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Almonertinib Treats Advanced NSCLC Patients With EGFR Mutations Who Are Safety Intolerant After Osimertinib Treatment
ClinicalTrials.gov study NCT04882345. IPD Sharing: NO. Countries: 0. Publications: 0.
the Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generatio
ClinicalTrials.gov study NCT05497076. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC
ClinicalTrials.gov study NCT05862194. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer
ClinicalTrials.gov study NCT05994339. IPD Sharing: NO. Countries: 0. Publications: 0.
JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety
ClinicalTrials.gov study NCT04874844. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT07256509. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Anti-BRAF mutation drug resistance enhances EGFR expression in melanomas [expression profiling]
GEO Series GSE45648. Homo sapiens. 4 samples. Type: Expression profiling by array.
Targeting cancers with EGFR exon 20 insertion mutations by exploiting a dependency on parallel SRC signalling
GEO Series GSE156832. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
Genome-wide DNA methylation analysis of driver gene-negative and EGFR-mutation lung adenocarcinoma and ajacent normal tissue
GEO Series GSE235414. Homo sapiens. 130 samples. Type: Methylation profiling by genome tiling array.
The HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR mutated and wildtype NSCLC cells
GEO Series GSE63784. Homo sapiens. 3 samples. Type: Genome variation profiling by SNP array.
Identification of clonal neoantigens derived from driver mutations in an EGFR mutated lung cancer patient benefitting from anti-PD-1
GEO Series GSE150972. Homo sapiens. 1 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.